Proliferative Potential and p53 Overexpression in Precursor and Early Stage Lesions of Bronchioloalveolar Lung Carcinoma

Am J Pathol. 1995 Apr;146(4):876-87.

Abstract

To elucidate the pathogenesis of bronchioloalveolar lung carcinoma (BAC), we evaluated the lesion size, growth fraction, and p53 overexpression of atypical adenomatous hyperplasia (AAH) and early stage BAC. AAH was classified as showing low grade or high grade atypia. AAH-like carcinoma, presumably very early stage BAC, was distinguished from AAH in that it exhibited remarkable atypia suggestive of malignant potential and from overt BAC in that it lacked unequivocal malignant features, including invasive/destructive growth. The growth fraction was determined immunohistochemically in terms of the Ki-67 labeling index. The overexpression of p53 was evaluated by assessing the nuclear accumulation of immunoreactive p53 protein. Both the lesion size and the growth fraction increased from low grade AAH, to high grade AAH, to AAH-like carcinoma, and to overt adenocarcinoma. The overexpression of p53 in AAH-like carcinoma was similar to that in overt adenocarcinoma and was more frequent than that in AAH. Our findings indicate that AAH, AAH-like carcinoma, and overt BAC represent different categories, although the cellular events occurring in these lesions presumably represent a continuous spectrum of the changes that are reflected in the cytomorphology and lesion size. The findings here suggest that AAH and AAH-like carcinomas constitute a population of heterogeneous lesions representing different steps toward overt BAC.

MeSH terms

  • Adenocarcinoma, Bronchiolo-Alveolar / chemistry
  • Adenocarcinoma, Bronchiolo-Alveolar / pathology*
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Hyperplasia / metabolism
  • Ki-67 Antigen
  • Lung Neoplasms / chemistry
  • Lung Neoplasms / pathology*
  • Male
  • Middle Aged
  • Neoplasm Proteins / analysis
  • Nuclear Proteins / analysis
  • Precancerous Conditions / chemistry
  • Precancerous Conditions / pathology*
  • Tumor Suppressor Protein p53 / biosynthesis*

Substances

  • Ki-67 Antigen
  • Neoplasm Proteins
  • Nuclear Proteins
  • Tumor Suppressor Protein p53